Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9176 - 9200 of 10579 in total
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational
Matched Iupac: … 3-[chloro({[(2R)-2-hydroxy-3-(piperidin-1-yl)propoxy]imino})methyl]pyridin-1-ium-1-olate …
Matched Salts cas: … 368860-21-3
PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Investigational
Matched Iupac: … N-(pyridazin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methylidene]piperidine-1-carboxamide …
TC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).
Investigational
Matched Iupac: … 3,5-difluoro-N-[(2S,3R)-2-[(pyridin-3-yl)methyl]-1-azabicyclo[2.2.2]octan-3-yl]benzamide …
RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).
Investigational
Matched Iupac: … 3-(2-fluorophenyl)-1-[(3S)-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]urea …
PAT-1251 is under investigation in clinical trial NCT04054245 (PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocytosis Myelofibrosis).
Investigational
Matched Iupac: … (3R,4R)-1-(3-{[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy}benzoyl)-4-fluoropyrrolidin-3-ol …
Experimental
Matched Synonyms: … 4-amino-N-(aminothioxomethyl)benzenesulfonamide …
Matched Iupac: … (4-aminobenzenesulfonyl)thiourea …
DCLL9718S is an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1). DCLL9718S is under investigation in clinical trial NCT03298516 (A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy).
Investigational
HPA-23 is an investigational antiviral compound.
Investigational
Matched Iupac: … henicosatungsten(6+) nonaantimony(3+) disodium(2+) heptadecaammonium hexaoctacontaoxidandiide …
Tarcocimab tedromer is under investigation in clinical trial NCT06270836 (A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR)).
Investigational
Clorobiocin is an aminocoumarin antibiotic, similar to novobiocin and coumermycin A1.
Experimental
Matched Iupac: … -7-yl}oxy)-5-hydroxy-3-methoxy-2,2-dimethyloxan-4-yl 5-methyl-1H-pyrrole-2-carboxylate ... (3R,4S,5R,6S)-6-({8-chloro-4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-2-oxo-2H-chromen …
Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis).
Investigational
Matched Iupac: … (methylsulfanyl)butanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]hexanoyl ... amino-2-[(2S)-2-[(2S)-2-[(2S)-2-(2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4- ... ]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-carboxypropanamido]butanedioic acid ... ]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]hexanoyl …
Experimental
Matched Iupac: … (2R)-3-(hydroxysulfanyl)propane-1,2-diol …
Experimental
Matched Iupac: … (2R)-3-(acetylsulfanyl)-2-aminopropanoic acid …
Experimental
Matched Iupac: … (2S)-2-acetamido-3-hydroxypropanoic acid …
Experimental
Matched Iupac: … 1-methyl-1H-imidazol-3-ium …
Experimental
Matched Iupac: … (2R)-2-amino-3-disulfanylpropanoic acid …
Experimental
Investigational
Matched Iupac: … [3-(N-hydroxyformamido)propyl]phosphonic acid …
Experimental
Matched Iupac: … (E)-N''-(3-azaniumylpropyl)-N-hydroxyguanidine …
Experimental
Matched Iupac: … 3-hydroxy-3,5,5-trioxotrivanadoxan-1-oylolate …
Isoamyl 2 Cyanoacrylate is under investigation in clinical trial NCT02698644 (Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate).
Investigational
Matched Iupac: … 3-methylbutyl 2-cyanoprop-2-enoate …
Experimental
Matched Iupac: … aluminium(3+) 2-aminoacetate hydrate dihydroxide …
Experimental
Matched Iupac: … 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane …
Methfuroxam is under investigation in clinical trial NCT01213407 (Dendritic Cell Cancer Vaccine for High-grade Glioma).
Investigational
Matched Iupac: … 2,4,5-trimethyl-N-phenylfuran-3-carboxamide …
Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Investigational
Matched Iupac: … 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine …
Salvianolic acid A is under investigation in clinical trial NCT03908242 (Phase I Study of Continuous Administration of Salvianolic Acid A Tablet).
Investigational
Matched Iupac: … (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-{2-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl} …
Displaying drugs 9176 - 9200 of 10579 in total